Hearing Recap: “Profits Over Patients: The PBM Business Model Under Scrutiny”
Representative Virginia Foxx questioned witnesses regarding the power PBMs exert over the distribution and accessibility of pharmaceutical medications.
The House Subcommittee on Health, Employment, Labor, and Pensions held a hearing to examine how pharmacy benefit managers (PBMs) contribute to rising drug costs and lack of transparency.
